Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
-Jie (Bruce) Ni and has no direct reports. Salary, Level A - $91,381 - $121,838 per annum + 17% superannuation Full time Fixed-term contract for 3 years Location: Kensington – Sydney, Australia About
-
Base Salary $109,263 - $121,054 + 17% superannuation About the opportunity We are currently seeking to appoint a Postdoctoral Research Fellow to work on a range of Artificial Intelligence in Education
-
to child and youth mental health in Australia Base Salary, Academic Level A, $109,263 - $121,054 p.a. + 17% superannuation About the opportunity The School of Psychology is currently seeking a Postdoctoral
-
Research Infrastructure? No Offer Description Full time, fixed term for 12 months Opportunity to advance research in AI Hardware Acceleration Base Salary $89,831 - $121,054 + 17% superannuation About the
-
cells Base salary, Level A, $105,117 p.a - $121,054 p.a. and generous employer’s contribution to superannuation About the opportunity The School of Physics are seeking to appoint a Postdoctoral
-
Full time, fixed term for 12 months Opportunity to advance research in AI Hardware Acceleration Base Salary $89,831 - $121,054 + 17% superannuation About the opportunity The School of Electrical and
-
interdisciplinary environment for studying the dynamics of complex physical systems. Base Salary, Academic Level A, $113,634 - $113,634 p.a + 17% superannuation. About the opportunity The School of Physics
-
time, fixed term for 24 months, with the possibility of extension Base Salary from level A ($113,400 - $121,054) or level B ($127,436 to $151,328) + 17% superannuation About the opportunity This is an
-
, Controlling the Risks”. We welcome applications from candidates with Level A, Level B or up to a level C (step 1) experience for this position. About us UNSW isn’t like other places you’ve worked. Yes, we’re a
-
About the opportunity The Cancer and Stem Cell Laboratory is dedicated to understanding how normal stem cells transform into cancer stem cells and to developing targeted therapies that eliminate